Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Published:2014-08-05 Issue:8 Volume:9 Page:e104346
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Qin,Yan Han,Liu Wenting,Zhen Hongchao,Yang Yifan,Cao Bangwei

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis;BH Goulart;J Hematol Oncol,2009

2. Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials;E Bria;Cancer,2007

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;HR Burris;J Clin Oncol,1997

4. Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis;JH Choi;Cancer Res Treat,2008

5. Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival;DR Xie;Jpn J Clin Oncol,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments;Frontiers in Oncology;2024-07-01

2. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11

3. The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis;Journal of Gastrointestinal Oncology;2022-08

4. Survival benefits and safety of chemotherapy regimens for pancreatic cancer: An umbrella review of meta-analyses of randomized controlled trials;Annals of Pancreatic Disorders and Treatment;2022-06-03

5. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-06